Statin Enhances Osteoblast Differentiation by Suppression of Runx2 Overexpression
-
- KAMADA Aiko
- Department of Biochemistry, Osaka Dental University, Japan
-
- IKEO Takashi
- Department of Biochemistry, Osaka Dental University, Japan
-
- TAMURA Isao
- Department of Biochemistry, Osaka Dental University, Japan
-
- GODA Seiji
- Department of Biochemistry, Osaka Dental University, Japan
-
- YOSHIKAWA Yoshihiro
- Department of Biochemistry, Osaka Dental University, Japan
-
- DOMAE Eisuke
- Graduate School of Dentistry (Biochemistry), Osaka Dental University, Japan
-
- KAWAMOTO Akiyo
- Department of Geriatric Dentistry, Osaka Dental University, Japan
-
- OKAZAKI Joji
- Department of Geriatric Dentistry, Osaka Dental University, Japan
-
- KOMASA Yutaka
- Department of Geriatric Dentistry, Osaka Dental University, Japan
-
- HAYASHI Hiroyuki
- Department of Endodontics, Osaka Dental University, Japan
-
- HOKUGO Akishige
- First Department of Oral and Maxillofacial Surgery, Osaka Dental University, Japan
-
- ISEKI Tomio
- First Department of Oral and Maxillofacial Surgery, Osaka Dental University, Japan
-
- MORITA Shosuke
- First Department of Oral and Maxillofacial Surgery, Osaka Dental University, Japan
この論文をさがす
抄録
It has recently been reported that statins, the cholesterol-lowering drug, activate the promoter of the bone morphogenic protein-2 (BMP-2) gene, and stimulate bone forma-tion. However, the mechanism of the stimulation of bone metabolism by statins is not precisely clarified. In this study, we investigated whether statins effect the expression of osteogenic master transcription factors, Runx2/Cbfa1 and Dlx5, as a downstream target of BMP-2. The human osteoblastic osteosarcoma cell line, SaOS-2, was used for this experiment. RT-PCR analysis demonstrated continuous overexpression of Runx2 in SaOS-2, though the expression was hardly observed in normal human osteoblasts. Therefore we considered SaOS-2 a model for the overexpression of the transcription factor. When the osteosarcoma cells were incubated with compactin, there was a significant decrease in mRNA level of Runx2 compared with controls (p<0.01). There appeared to be no overall changes in Dlx5. These results demonstrate that statins suppress the overexpression of Runx2 mRNA, and it hardly effects the expression of Dlx5. It is known that Runx2 is essential for the initial osteoblastic differentiation, but it inhibits the final differentiation. Hence, it is indicated that statins promote not only the initial osteoblastic differentiation but also the final differentiation through regulation of transcription factors.
収録刊行物
-
- Journal of Oral Tissue Engineering
-
Journal of Oral Tissue Engineering 4 (1), 9-16, 2006
日本再生歯科医学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282680202552320
-
- NII論文ID
- 130004456568
- 110006263691
-
- NII書誌ID
- AA1195240X
-
- ISSN
- 18800823
- 13489623
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可